Abstract
Impact of the Oral Orexin Receptor 2 Agonist TAK-994 on Sustained Attention in Patients with Narcolepsy Type 1: Exploratory Results from a Phase 2 Study (P11-9.012)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have